RBM47 and acute myeloid leukemia: Next, we validated the expression of selected RBPs, CLK4, RBM47 and ERI1 from module I, and NSUN7 from module II, in samples from patients with AML (n = 28) using qRT-PCR and compared the results with those obtained using age-matched normal bone marrow samples (Figure 4F).